Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hauschke

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1991
Sample size determination for bioequivalence assessment by means of confidence intervalsE Diletti, D Hauschke, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Sample size determination for bioequivalence assessment by means of confidence intervalsE Diletti, D Hauschke, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1992
Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43E Diletti, D Hauschke, V W Steinijans
Pulmonary Pharmacology|October 1, 1994
Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSFD Häfner, P G Germann, D Hauschke
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injuryD Häfner, P G Germann, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1990
A distribution-free procedure for the statistical analysis of bioequivalence studiesD Hauschke, V W Steinijans, E Diletti
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Biometrical methods for the proof of efficacy in regulatory submissions. Non-inferiority in clinical studies]J Röhmel, D Hauschke, A Koch, et al.
Clinical Pharmacokinetics|April 1, 1992
Controversies in bioequivalence studiesV W Steinijans, D Hauschke, J H Jonkman
Statistics in Medicine|February 17, 1999
Sample size determination for proving equivalence based on the ratio of two means for normally distributed dataD Hauschke, M Kieser, E Diletti, et al.
Pathology, Research and Practice|June 1, 1992
Comparison of the ECL-cell frequency in the stomachs of 3 different rat strainsK Tuch, D Ockert, D Hauschke, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1991
Sample size determination for bioequivalence assessment by means of confidence intervalsE Diletti, D Hauschke, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Sample size determination for bioequivalence assessment by means of confidence intervalsE Diletti, D Hauschke, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1992
Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43E Diletti, D Hauschke, V W Steinijans
Pulmonary Pharmacology|October 1, 1994
Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSFD Häfner, P G Germann, D Hauschke
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injuryD Häfner, P G Germann, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1990
A distribution-free procedure for the statistical analysis of bioequivalence studiesD Hauschke, V W Steinijans, E Diletti
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Biometrical methods for the proof of efficacy in regulatory submissions. Non-inferiority in clinical studies]J Röhmel, D Hauschke, A Koch, et al.
Clinical Pharmacokinetics|April 1, 1992
Controversies in bioequivalence studiesV W Steinijans, D Hauschke, J H Jonkman
Statistics in Medicine|February 17, 1999
Sample size determination for proving equivalence based on the ratio of two means for normally distributed dataD Hauschke, M Kieser, E Diletti, et al.
Pathology, Research and Practice|June 1, 1992
Comparison of the ECL-cell frequency in the stomachs of 3 different rat strainsK Tuch, D Ockert, D Hauschke, et al.
Pageof 5